LENZ Therapeutics (LENZ) Cash from Operations (2020 - 2026)
LENZ Therapeutics (LENZ) reported Cash from Operations of 33582000.0 for Q1 2026, down 109.25% year-over-year from 363178920.49 in Q1 2025, and down 1.69% quarter-over-quarter from 33025000.0 in Q4 2025.
LENZ Therapeutics (LENZ) Cash from Operations (2020 - 2026) Analysis & Trends
LENZ Therapeutics (LENZ) has 7 years of Cash from Operations data on file, last reported at 33582000.0 in Q1 2026.
- Cash from Operations for Q1 2026 came in at 33582000.0, down 109.25% year-over-year; the trailing twelve-month figure through Mar 2026 was 86703000.0 (down 68.35% YoY), and the FY2025 annual result was 69170000.0, down 16.47% from the prior year.
- Cash from Operations retreated to 33582000.0 in Q1 2026 per LENZ's latest filing, from 33025000.0 in the prior quarter.
- Over five years, Cash from Operations peaked at 8588000.0 in Q3 2025 and troughed at 33582000.0 in Q1 2026.
- A 5-year average of 18264882.35 and a median of 16049000.0 in 2025 frame the typical range for Cash from Operations.
- The sharpest annual moves came in 2024 and 2025: Cash from Operations surged 56.71% in 2024, then plunged 263.79% in 2025.
- A 5-year view of Cash from Operations shows it stood at 22429000.0 in 2022, then grew by 6.5% to 20970000.0 in 2023, then surged by 56.71% to 9078000.0 in 2024, then sank by 263.79% to 33025000.0 in 2025, then fell by 1.69% to 33582000.0 in 2026.
- Business Quant data shows LENZ's Cash from Operations at 33582000.0 in Q1 2026, 33025000.0 in Q4 2025, and 8588000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Ops. (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | -1.67 Mn |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | -12.20 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | -2.49 Mn |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 1.43 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | LENZ Therapeutics | 192.19 Mn | 192.19 Mn | 825,000.00 | -33.58 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -33.58 Mn |
| Mar 31, 2026 | -33.58 Mn |
| Dec 31, 2025 | -33.03 Mn |
| Dec 31, 2025 | -33.03 Mn |
| Sep 30, 2025 | -8.59 Mn |
| Sep 30, 2025 | -8.59 Mn |
| Jun 30, 2025 | -11.51 Mn |
| Jun 30, 2025 | -11.51 Mn |
| Mar 31, 2025 | -16.05 Mn |
| Mar 31, 2025 | -16.05 Mn |
| Dec 31, 2024 | -9.08 Mn |
| Dec 31, 2024 | -9.08 Mn |
| Sep 30, 2024 | -10.58 Mn |
| Sep 30, 2024 | -10.58 Mn |
| Jun 30, 2024 | -15.80 Mn |
| Jun 30, 2024 | -15.80 Mn |
| Mar 31, 2024 | -23.94 Mn |
| Mar 31, 2024 | -23.94 Mn |
| Dec 31, 2023 | -20.97 Mn |
| Dec 31, 2023 | -20.97 Mn |